Could a genetically tweaked bacteria shrink Hard-to-Treat tumors?
Disease control
Recruiting now
This study tests a genetically modified, weakened bacteria (T3P-Y058-739) in about 100 adults with advanced solid tumors that have no standard treatment options. The bacteria is given alone or with the immunotherapy drug pembrolizumab, either as an injection into the tumor or int…
Phase: PHASE1, PHASE2 • Sponsor: T3 Pharmaceuticals AG • Aim: Disease control
Last updated May 14, 2026 12:03 UTC